ImmunologybioRxivPreprint
CD28-Selective Inhibition Prolongs Non-Human Primate Kidney Transplant Survival
B. P. Lovasik, S. C. Kim, L. Higginbotham…·A. B. Adams
This study tests a CD28-selective therapy in non-human primates, showing extended kidney transplant survival compared to belatacept alone.
DOI 10.1101/2023.05.03.539333